_________
C004
à÷ñ èé àì áéåôøîñåèé÷ìñ áò"î
2
Public
X T L BIOPHARMACEUTICALS LTD
4313
Corporation no:
520039470
Stock Exchange/Market:
à÷ñ èé àì
1996
352
Hasapir
3
,
Nes Ziona
76100
,
,
Tel:
08-9304444
,
Fax:
08-9304445
E.mail address:
rcohen@xtlbio.com
Date of transmission:
15/08/2007
Time of broadcast:
14:53
14:50:37
Reference:
2007-02-359122
Israel Securities Authority
Tel Aviv Stock Exchange
www.isa.gov.il
www.tase.co.il
Immediate report on other matter
Don't use this form if there is more adequate one
XTL's Annual General Meeting (“AGM”) and Extraordinary General Meeting (“EGM”)
Attached file
AGMannouncement81507_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
XENOGRAFT TECHNOLOGIES LTD
Date of revision of form structure:
28/06/2007
Name of the Signatory:
:
Kantor Ronen
,
,
Position of Signatory in the reporting corporation:
Legal Consultant & Corporate Secretary
Abba Hillel Silver
Telephone:
03-6133371
,
Facsimile:
03-6133372
,
E-mail:
rkantor@kantor-law.com